Isomorphic Labs Talks to Raise $5 Billion at $50 Billion Valuation
AI summary
Bloomberg reports that Alphabet-backed Isomorphic Labs is in talks to raise roughly $5 billion for AI drug discovery. The proposed round could value the company at about $50 billion, following its $2.1 billion raise led by Thrive Capital in May. The financing has not closed, and its terms and valuation could change.
In-depth insight
The proposed financing would provide substantial capital for Isomorphic Labs' drug-development programs, although the company has not yet entered human clinical trials.
This source provides an excerpt. Continue reading on the original site.